Home > Healthcare & Medical Devices > Point of Care Testing Market > Table of Contents

Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-Abuse Testing, Fecal Occult Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI3086
  • Published Date: Nov 2021
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definition

1.2    Base estimates & working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia pacific

1.2.4    Latin America

1.2.5    Middle East & Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Point of care testing industry 3600 synopsis, 2016 – 2027 (USD Million)

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Technology trends

2.1.4    Prescription trends

2.1.5    Application trends

2.1.6    End-use trends

2.1.7    Regional trends

Chapter 3   Point of Care Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Upward trend in disease prevalence among developing countries

3.3.1.2    Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America

3.3.1.3    Technological advancements

3.3.1.4    Increasing R&D investment

3.3.1.5    Growing geriatric population base globally

3.3.2    Industry pitfalls and challenges

3.3.2.1    Stringent regulatory framework

3.3.2.2    High cost of product development

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By technology

3.4.3    By prescription

3.4.4    By application

3.4.5    By end-use

3.5    COVID-19 impact analysis

3.6    Pricing analysis, by cardiac markers, 2020

3.7    Regulatory landscape

3.8    Technology landscape

3.9    Company share analysis, 2020

3.9.1    Global market share analysis, 2020

3.9.2    North America

3.9.3    Europe

3.9.4    Asia Pacific

3.9.5    Latin America

3.9.6    Middle East and Africa

3.10    Porter’s analysis

3.11    Competitive landscape,2020

3.11.1    Company matrix analysis

3.12    PESTEL analysis

Chapter 4   Point of Care Testing Market, By Product

4.1    Key segment trends

4.2    Glucose monitoring

4.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.2.2    Strips

4.2.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.2.3    Meters

4.2.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.2.4    Lancets

4.2.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.3    Cardiometabolic testing products

4.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2    Cardiac marker testing products

4.3.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.2    High-sensitivity troponin I (hsTnl)

4.3.2.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.3    Brain natriuretic peptide (BNP)

4.3.2.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.4    D-dimer

4.3.2.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.5    Creatine kinase-MB (CK-MB)

4.3.2.5.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.6    Myoglobin

4.3.2.6.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.2.7    Others

4.3.2.7.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.3    Blood Gas/Electrolytes testing products

4.3.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.3.4    HBA1C testing products

4.3.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.4    Infectious disease testing products

4.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.2    Influenza testing products

4.4.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.3    HIV testing products

4.4.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.4    Hepatitis C testing products

4.4.4.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.5    Sexually transmitted disease (STD) testing products

4.4.5.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.6    Healthcare-associated Infection (HAI) testing products

4.4.6.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.7    Respiratory infection testing products

4.4.7.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.8    Tropical disease testing products

4.4.8.1    Market size, by region, 2016 - 2027 (USD Million)

4.4.9    Other infectious diseases testing products

4.4.9.1    Market size, by region, 2016 - 2027 (USD Million)

4.5    Coagulation testing products

4.5.1    Market size, by region, 2016 - 2027 (USD Million)

4.5.2    PT/INR testing products

4.5.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.5.3    Activated clotting time (ACT/APTT) testing products

4.5.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.6    Pregnancy and fertility testing products

4.6.1    Market size, by region, 2016 - 2027 (USD Million)

4.6.2    Pregnancy testing products

4.6.2.1    Market size, by region, 2016 - 2027 (USD Million)

4.6.3    Fertility testing products

4.6.3.1    Market size, by region, 2016 - 2027 (USD Million)

4.7    Tumor/Cancer marker testing products

4.7.1    Market size, by region, 2016 - 2027 (USD Million)

4.8    Urinalysis testing products

4.8.1    Market size, by region, 2016 - 2027 (USD Million)

4.9    Cholesterol testing products

4.9.1    Market size, by region, 2016 - 2027 (USD Million)

4.10    Hematology testing products

4.10.1    Market size, by region, 2016 - 2027 (USD Million)

4.11    Drug-of-Abuse (DoA) testing products

4.11.1    Market size, by region, 2016 - 2027 (USD Million)

4.12    Fecal occult testing products

4.12.1    Market size, by region, 2016 - 2027 (USD Million)

4.13    Other products

4.13.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 5   Point of Care Testing Market, By Technology

5.1    Key segment trends

5.2    Lateral flow assays

5.2.1    Market size, by region, 2016 - 2027 (USD Million)

5.3    Dipsticks

5.3.1    Market size, by region, 2016 - 2027 (USD Million)

5.4    Microfluidics

5.4.1    Market size, by region, 2016 - 2027 (USD Million)

5.5    Molecular diagnostics

5.5.1    Market size, by region, 2016 - 2027 (USD Million)

5.6    Immunoassays

5.6.1    Market size, by region, 2016 - 2027 (USD Million)

5.7    Agglutination assays

5.7.1    Market size, by region, 2016 - 2027 (USD Million)

5.8    Flow-through

5.8.1    Market size, by region, 2016 - 2027 (USD Million)

5.9    Solid phase

5.9.1    Market size, by region, 2016 - 2027 (USD Million)

5.10    Biosensors

5.10.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 6   Point of Care Testing Market, By Prescription

6.1    Key segment trends

6.2    OTC testing

6.2.1    Market size, by region, 2016 - 2027 (USD Million)

6.3    Prescription-based testing

6.3.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 7   Point of Care Testing Market, By Application

7.1    Key segment trends

7.2    Cardio metabolic testing

7.2.1    Market size, by region, 2016 - 2027 (USD Million)

7.3    Infectious disease testing

7.3.1    Market size, by region, 2016 - 2027 (USD Million)

7.4    Nephrology testing

7.4.1    Market size, by region, 2016 - 2027 (USD Million)

7.5    Drug-of-Abuse (DoA) testing

7.5.1    Market size, by region, 2016 - 2027 (USD Million)

7.6    Blood glucose testing

7.6.1    Market size, by region, 2016 - 2027 (USD Million)

7.7    Pregnancy testing

7.7.1    Market size, by region, 2016 - 2027 (USD Million)

7.8    Cancer biomarker testing

7.8.1    Market size, by region, 2016 - 2027 (USD Million)

7.9    Other applications

7.9.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 8   Point of Care Testing Market, By End-use

8.1    Key segment trends

8.2    Hospitals

8.2.1    Market size, by region, 2016 - 2027 (USD Million)

8.3    Diagnostic centers

8.3.1    Market size, by region, 2016 - 2027 (USD Million)

8.4    Research laboratories

8.4.1    Market size, by region, 2016 - 2027 (USD Million)

8.5    Home-care settings

8.5.1    Market size, by region, 2016 - 2027 (USD Million)

8.6    Others

8.6.1    Market size, by region, 2016 - 2027 (USD Million)

Chapter 9   Point of Care Testing Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    Market size, by country, 2016 – 2027 (USD Million)

9.2.2    Market size, by product, 2016 – 2027 (USD Million)

9.2.2.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.2.2.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.2.2.2.1    Market size, by cardiac marker testing product, 2016 – 2027 (USD Million)

9.2.2.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.2.2.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.2.2.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.2.3    Market size, by technology, 2016 – 2027 (USD Million)

9.2.4    Market size, by prescription, 2016 – 2027 (USD Million)

9.2.5    Market size, by application, 2016 – 2027 (USD Million)

9.2.6    Market size, by end-use, 2016 – 2027 (USD Million)

9.2.7    U.S.

9.2.7.1    Market size, by product, 2016 – 2027 (USD Million)

9.2.7.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.2.7.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.2.7.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.2.7.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.2.7.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.2.7.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.2.7.2    Market size, by technology, 2016 – 2027 (USD Million)

9.2.7.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.2.7.4    Market size, by application, 2016 – 2027 (USD Million)

9.2.7.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.2.8    Canada

9.2.8.1    Market size, by product, 2016 – 2027 (USD Million)

9.2.8.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.2.8.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.2.8.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.2.8.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.2.8.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.2.8.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.2.8.2    Market size, by technology, 2016 – 2027 (USD Million)

9.2.8.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.2.8.4    Market size, by application, 2016 – 2027 (USD Million)

9.2.8.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.3    Europe

9.3.1    Market size, by country, 2016 – 2027 (USD Million)

9.3.2    Market size, by product, 2016 – 2027 (USD Million)

9.3.2.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.2.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.2.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.2.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.2.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.2.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.3    Market size, by technology, 2016 – 2027 (USD Million)

9.3.4    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.5    Market size, by application, 2016 – 2027 (USD Million)

9.3.6    Market size, by end-use, 2016 – 2027 (USD Million)

9.3.7    Germany

9.3.7.1    Market size, by product, 2016 – 2027 (USD Million)

9.3.7.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.7.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.7.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.7.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.7.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.7.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.7.2    Market size, by technology, 2016 – 2027 (USD Million)

9.3.7.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.7.4    Market size, by application, 2016 – 2027 (USD Million)

9.3.7.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.3.8    UK

9.3.8.1    Market size, by product, 2016 – 2027 (USD Million)

9.3.8.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.8.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.8.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.8.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.8.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.8.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.8.2    Market size, by technology, 2016 – 2027 (USD Million)

9.3.8.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.8.4    Market size, by application, 2016 – 2027 (USD Million)

9.3.8.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.3.9    France

9.3.9.1    Market size, by product, 2016 – 2027 (USD Million)

9.3.9.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.9.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.9.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.9.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.9.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.9.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.9.2    Market size, by technology, 2016 – 2027 (USD Million)

9.3.9.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.9.4    Market size, by application, 2016 – 2027 (USD Million)

9.3.9.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.3.10    Spain

9.3.10.1    Market size, by product, 2016 – 2027 (USD Million)

9.3.10.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.10.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.10.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.10.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.10.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.10.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.10.2    Market size, by technology, 2016 – 2027 (USD Million)

9.3.10.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.10.4    Market size, by application, 2016 – 2027 (USD Million)

9.3.10.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.3.11    Italy

9.3.11.1    Market size, by product, 2016 – 2027 (USD Million)

9.3.11.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.3.11.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.3.11.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.3.11.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.3.11.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.3.11.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.3.11.2    Market size, by technology, 2016 – 2027 (USD Million)

9.3.11.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.3.11.4    Market size, by application, 2016 – 2027 (USD Million)

9.3.11.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.4    Asia Pacific

9.4.1    Market size, by country, 2016 – 2027 (USD Million)

9.4.2    Market size, by product, 2016 – 2027 (USD Million)

9.4.2.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.4.2.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.4.2.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.4.2.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.4.2.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.4.2.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.4.3    Market size, by technology, 2016 – 2027 (USD Million)

9.4.4    Market size, by prescription, 2016 – 2027 (USD Million)

9.4.5    Market size, by application, 2016 – 2027 (USD Million)

9.4.6    Market size, by end-use, 2016 – 2027 (USD Million)

9.4.7    China

9.4.7.1    Market size, by product, 2016 – 2027 (USD Million)

9.4.7.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.4.7.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.4.7.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.4.7.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.4.7.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.4.7.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.4.7.2    Market size, by technology, 2016 – 2027 (USD Million)

9.4.7.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.4.7.4    Market size, by application, 2016 – 2027 (USD Million)

9.4.7.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.4.8    Japan

9.4.8.1    Market size, by product, 2016 – 2027 (USD Million)

9.4.8.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.4.8.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.4.8.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.4.8.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.4.8.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.4.8.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.4.8.2    Market size, by technology, 2016 – 2027 (USD Million)

9.4.8.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.4.8.4    Market size, by application, 2016 – 2027 (USD Million)

9.4.8.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.4.9    India

9.4.9.1    Market size, by product, 2016 – 2027 (USD Million)

9.4.9.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.4.9.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.4.9.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.4.9.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.4.9.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.4.9.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.4.9.2    Market size, by technology, 2016 – 2027 (USD Million)

9.4.9.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.4.9.4    Market size, by application, 2016 – 2027 (USD Million)

9.4.9.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.4.10    Australia

9.4.10.1    Market size, by product, 2016 – 2027 (USD Million)

9.4.10.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.4.10.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.4.10.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.4.10.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.4.10.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.4.10.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.4.10.2    Market size, by technology, 2016 – 2027 (USD Million)

9.4.10.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.4.10.4    Market size, by application, 2016 – 2027 (USD Million)

9.4.10.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.5    Latin America

9.5.1    Market size, by country, 2016 – 2027 (USD Million)

9.5.2    Market size, by product, 2016 – 2027 (USD Million)

9.5.2.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.5.2.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.5.2.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.5.2.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.5.2.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.5.2.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.5.3    Market size, by technology, 2016 – 2027 (USD Million)

9.5.4    Market size, by prescription, 2016 – 2027 (USD Million)

9.5.5    Market size, by application, 2016 – 2027 (USD Million)

9.5.6    Market size, by end-use, 2016 – 2027 (USD Million)

9.5.7    Brazil

9.5.7.1    Market size, by product, 2016 – 2027 (USD Million)

9.5.7.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.5.7.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.5.7.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.5.7.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.5.7.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.5.7.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.5.7.2    Market size, by technology, 2016 – 2027 (USD Million)

9.5.7.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.5.7.4    Market size, by application, 2016 – 2027 (USD Million)

9.5.7.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.5.8    Mexico

9.5.8.1    Market size, by product, 2016 – 2027 (USD Million)

9.5.8.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.5.8.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.5.8.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.5.8.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.5.8.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.5.8.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.5.8.2    Market size, by technology, 2016 – 2027 (USD Million)

9.5.8.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.5.8.4    Market size, by application, 2016 – 2027 (USD Million)

9.5.8.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.6    Middle East and Africa

9.6.1    Market size, by country, 2016 – 2027 (USD Million)

9.6.2    Market size, by product, 2016 – 2027 (USD Million)

9.6.2.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.6.2.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.6.2.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.6.2.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.6.2.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.6.2.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.6.3    Market size, by technology, 2016 – 2027 (USD Million)

9.6.4    Market size, by prescription, 2016 – 2027 (USD Million)

9.6.5    Market size, by application, 2016 – 2027 (USD Million)

9.6.6    Market size, by end-use, 2016 – 2027 (USD Million)

9.6.7    South Africa

9.6.7.1    Market size, by product, 2016 – 2027 (USD Million)

9.6.7.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.6.7.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.6.7.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.6.7.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.6.7.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.6.7.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.6.7.2    Market size, by technology, 2016 – 2027 (USD Million)

9.6.7.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.6.7.4    Market size, by application, 2016 – 2027 (USD Million)

9.6.7.5    Market size, by end-use, 2016 – 2027 (USD Million)

9.6.8    Saudi Arabia

9.6.8.1    Market size, by product, 2016 – 2027 (USD Million)

9.6.8.1.1    Market size, by glucose monitoring, 2016 – 2027 (USD Million)

9.6.8.1.2    Market size, by cardiometabolic testing products, 2016 – 2027 (USD Million)

9.6.8.1.2.1    Market size, by cardiac marker testing products, 2016-2027 (USD Million)

9.6.8.1.3    Market size, by infectious disease testing products, 2016 – 2027 (USD Million)

9.6.8.1.4    Market size, by coagulation testing products, 2016 – 2027 (USD Million)

9.6.8.1.5    Market size, by pregnancy and fertility testing products, 2016 – 2027 (USD Million)

9.6.8.2    Market size, by technology, 2016 – 2027 (USD Million)

9.6.8.3    Market size, by prescription, 2016 – 2027 (USD Million)

9.6.8.4    Market size, by application, 2016 – 2027 (USD Million)

9.6.8.5    Market size, by end-use, 2016 – 2027 (USD Million)

Chapter 10   Company Profiles

10.1    Competitive dashboard

10.2    Abaxis, Inc.

10.2.1    Business overview

10.2.2    Financial data

10.2.3    Product landscape

10.2.4    Strategic outlook

10.2.5    SWOT analysis

10.3    Abbott Laboratories

10.3.1    Business overview

10.3.2    Financial data

10.3.3    Product landscape

10.3.4    Strategic outlook

10.3.5    SWOT analysis

10.4    Accubiotech Co, Ltd.

10.4.1    Business overview

10.4.2    Financial data

10.4.3    Product landscape

10.4.4    Strategic outlook

10.4.5    SWOT analysis

10.5    ACON Laboratories, Inc

10.5.1    Business overview

10.5.2    Financial data

10.5.3    Product landscape

10.5.4    Strategic outlook

10.5.5    SWOT analysis

10.6    Becton, Dickinson and Company

10.6.1    Business overview

10.6.2    Financial data

10.6.3    Product landscape

10.6.4    Strategic outlook

10.6.5    SWOT analysis

10.7    Biolytical Laboratories

10.7.1    Business overview

10.7.2    Financial data

10.7.3    Product landscape

10.7.4    Strategic outlook

10.7.5    SWOT analysis

10.8    BioMrieux SA

10.8.1    Business overview

10.8.2    Financial data

10.8.3    Product landscape

10.8.4    Strategic outlook

10.8.5    SWOT analysis

10.9    Bio-Rad Laboratories, Inc

10.9.1    Business overview

10.9.2    Financial data

10.9.3    Product landscape

10.9.4    Strategic outlook

10.9.5    SWOT analysis

10.10    Danaher Corporation (HemoCue)

10.10.1    Business overview

10.10.2    Financial data

10.10.3    Product landscape

10.10.4    Strategic outlook

10.10.5    SWOT analysis

10.11    Dexcom, Inc

10.11.1    Business overview

10.11.2    Financial data

10.11.3    Product landscape

10.11.4    Strategic outlook

10.11.5    SWOT analysis

10.12    Dragerwerk Ag & Co

10.12.1    Business overview

10.12.2    Financial data

10.12.3    Product landscape

10.12.4    Strategic outlook

10.12.5    SWOT analysis

10.13    LifeScan IP Holdings, LLC

10.13.1    Business overview

10.13.2    Financial data

10.13.3    Product landscape

10.13.4    Strategic outlook

10.13.5    SWOT analysis

10.14    Medtronic

10.14.1    Business overview

10.14.2    Financial data

10.14.3    Product landscape

10.14.4    Strategic outlook

10.14.5    SWOT analysis

10.15    Meridian Bioscience, Inc

10.15.1    Business overview

10.15.2    Financial data

10.15.3    Product landscape

10.15.4    Strategic outlook

10.15.5    SWOT analysis

10.16    Nova Biomedical

10.16.1    Business overview

10.16.2    Financial data

10.16.3    Product landscape

10.16.4    Strategic outlook

10.16.5    SWOT analysis

10.17    Orasure Technologies, Inc

10.17.1    Business overview

10.17.2    Financial data

10.17.3    Product landscape

10.17.4    Strategic outlook

10.17.5    SWOT analysis

10.18    F Hoffmann-La Roche Ltd

10.18.1    Business overview

10.18.2    Financial data

10.18.3    Product landscape

10.18.4    Strategic outlook

10.18.5    SWOT analysis

10.19    Siemens Healthineers

10.19.1    Business overview

10.19.2    Financial data

10.19.3    Product landscape

10.19.4    Strategic outlook

10.19.5    SWOT analysis

10.20    Sysmex Corporation

10.20.1    Business overview

10.20.2    Financial data

10.20.3    Product landscape

10.20.4    Strategic outlook

10.20.5    SWOT analysis

10.21    Trinity Biotech

10.21.1    Business overview

10.21.2    Financial data

10.21.3    Product landscape

10.21.4    Strategic outlook

10.21.5    SWOT analysis
 

Data Tables

TABLE 1.    Global point of care testing market, 2016 - 2020 (USD Million)

TABLE 2.    Global point of care testing market, 2021 - 2027 (USD Million)

TABLE 3.    Global point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 4.    Global Point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 5.    Global point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 6.    Global point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 7.    Global point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 8.    Global point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 9.    Global point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 10.  Global point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 11.  Global point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 12.  Global point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 13.  Global point of care testing market, by region, 2016 - 2020 (USD Million)

TABLE 14.  Global point of care testing market, by region, 2021 - 2027 (USD Million)

TABLE 15.  Industry impact forces

TABLE 16.  POCT tests for COVID-19 approved from various regulatory body

TABLE 17.  Pricing analysis, by cardiac marker, 2020

TABLE 18.  Glucose monitoring market size, by region, 2016 - 2020 (USD Million)

TABLE 19.  Glucose monitoring market size, by region, 2021 - 2027 (USD Million)

TABLE 20.  Strips market size, by region, 2016 - 2020 (USD Million)

TABLE 21.  Strips market size, by region, 2021 - 2027 (USD Million)

TABLE 22.  Meters market size, by region, 2016 - 2020 (USD Million)

TABLE 23.  Meters market size, by region, 2021 - 2027 (USD Million)

TABLE 24.  Lancets market size, by region, 2016 - 2020 (USD Million)

TABLE 25.  Lancets market size, by region, 2021 - 2027 (USD Million)

TABLE 26.  Cardiometabolic market size, by region, 2016 - 2020 (USD Million)

TABLE 27.  Cardiometabolic market size, by region, 2021 - 2027 (USD Million)

TABLE 28.  Cardiac market size, by region, 2016 - 2020 (USD Million)

TABLE 29.  Cardiac market size, by region, 2021 - 2027 (USD Million)

TABLE 30.  hsTnl market size, by region, 2016 - 2020 (USD Million)

TABLE 31.  hsTnl market size, by region, 2021 - 2027 (USD Million)

TABLE 32.  BNP market size, by region, 2016 - 2020 (USD Million)

TABLE 33.  BNP market size, by region, 2021 - 2027 (USD Million)

TABLE 34.  D-dimer market size, by region, 2016 - 2020 (USD Million)

TABLE 35.  D-dimer market size, by region, 2021 - 2027 (USD Million)

TABLE 36.  CK-MB market size, by region, 2016 - 2020 (USD Million)

TABLE 37.  CK-MB market size, by region, 2021 - 2027 (USD Million)

TABLE 38.  Myoglobin market size, by region, 2016 - 2020 (USD Million)

TABLE 39.  Myoglobin market size, by region, 2021 - 2027 (USD Million)

TABLE 40.  Others market size, by region, 2016 - 2020 (USD Million)

TABLE 41.  Others market size, by region, 2021 - 2027 (USD Million)

TABLE 42.  Blood gas/electrolytes testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 43.  Blood gas/electrolytes testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 44.  HBA1C testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 45.  HBA1C testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 46.  Infectious disease testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 47.  Infectious disease testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 48.  Influenza testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 49.  Influenza testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 50.  HIV testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 51.  HIV testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 52.  Hepatitis C testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 53.  Hepatitis C testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 54.  Sexually transmitted disease (STD) testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 55.  Sexually transmitted disease (STD) testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 56.  Healthcare-associated infection (HAI) testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 57.  Healthcare-associated infection (HAI) testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 58.  Respiratory infection testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 59.  Respiratory infection testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 60.  Tropical disease testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 61.  Tropical disease testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 62.  Other infectious diseases testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 63.  Other infectious diseases testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 64.  Coagulation testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 65.  Coagulation testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 66.  PT/INR testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 67.  PT/INR testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 68.  Activated clotting time (ACT/APTT) testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 69.  Activated clotting time (ACT/APTT) testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 70.  Pregnancy and fertility testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 71.  Pregnancy and fertility testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 72.  Pregnancy testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 73.  Pregnancy testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 74.  Fertility testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 75.  Fertility testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 76.  Tumor/cancer marker testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 77.  Tumor/cancer marker testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 78.  Urinalysis testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 79.  Urinalysis testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 80.  Cholesterol testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 81.  Cholesterol testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 82.  Hematology testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 83.  Hematology testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 84.  Drug-of-Abuse testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 85.  Drug-of-Abuse testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 86.  Fecal occult testing products market size, by region, 2016 - 2020 (USD Million)

TABLE 87.  Fecal occult testing products market size, by region, 2021 - 2027 (USD Million)

TABLE 88.  Other products market size, by region, 2016 - 2020 (USD Million)

TABLE 89.  Other products market size, by region, 2021 - 2027 (USD Million)

TABLE 90.  Lateral flow assays market size, by region, 2016 - 2020 (USD Million)

TABLE 91.  Lateral flow assays market size, by region, 2021 - 2027 (USD Million)

TABLE 92.  Dipsticks market size, by region, 2016 - 2020 (USD Million)

TABLE 93.  Dipsticks market size, by region, 2021 - 2027 (USD Million)

TABLE 94.  Microfluidics market size, by region, 2016 - 2020 (USD Million)

TABLE 95.  Microfluidics market size, by region, 2021 - 2027 (USD Million)

TABLE 96.  Molecular diagnostics market size, by region, 2016 - 2020 (USD Million)

TABLE 97.  Molecular diagnostics market size, by region, 2021 - 2027 (USD Million)

TABLE 98.  Immunoassays market size, by region, 2016 - 2020 (USD Million)

TABLE 99.  Immunoassays market size, by region, 2021 - 2027 (USD Million)

TABLE 100. Agglutination assays market size, by region, 2016 - 2020 (USD Million)

TABLE 101. Agglutination assays market size, by region, 2021 - 2027 (USD Million)

TABLE 102. Flow-through market size, by region, 2016 - 2020 (USD Million)

TABLE 103. Flow-through market size, by region, 2021 - 2027 (USD Million)

TABLE 104. Solid phase market size, by region, 2016 - 2020 (USD Million)

TABLE 105. Solid phase market size, by region, 2021 - 2027 (USD Million)

TABLE 106. Biosensors market size, by region, 2016 - 2020 (USD Million)

TABLE 107. Biosensors market size, by region, 2021 - 2027 (USD Million)

TABLE 108. OTC testing market size, by region, 2016 - 2020 (USD Million)

TABLE 109. OTC testing market size, by region, 2021 - 2027 (USD Million)

TABLE 110. Prescription-based testing market size, by region, 2016 - 2020 (USD Million)

TABLE 111. Prescription-based testing market size, by region, 2021 - 2027 (USD Million)

TABLE 112. Cardio metabolic testing market size, by region, 2016 - 2020 (USD Million)

TABLE 113. Cardio metabolic testing market size, by region, 2021 - 2027 (USD Million)

TABLE 114. Infectious disease testing market size, by region, 2016 - 2020 (USD Million)

TABLE 115. Infectious disease testing market size, by region, 2021 - 2027 (USD Million)

TABLE 116. Nephrology testing market size, by region, 2016 - 2020 (USD Million)

TABLE 117. Nephrology testing market size, by region, 2021 - 2027 (USD Million)

TABLE 118. Drug-of-abuse testing market size, by region, 2016 - 2020 (USD Million)

TABLE 119. Drug-of-abuse testing market size, by region, 2021 - 2027 (USD Million)

TABLE 120. Blood glucose testing market size, by region, 2016 - 2020 (USD Million)

TABLE 121. Blood glucose testing market size, by region, 2021 - 2027 (USD Million)

TABLE 122. Pregnancy testing market size, by region, 2016 - 2020 (USD Million)

TABLE 123. Pregnancy testing market size, by region, 2021 - 2027 (USD Million)

TABLE 124. Cancer biomarker testing market size, by region, 2016 - 2020 (USD Million)

TABLE 125. Cancer biomarker testing market size, by region, 2021 - 2027 (USD Million)

TABLE 126. Other applications market size, by region, 2016 - 2020 (USD Million)

TABLE 127. Other applications market size, by region, 2021 - 2027 (USD Million)

TABLE 128. Hospitals market size, by region, 2016 - 2020 (USD Million)

TABLE 129. Hospitals market size, by region, 2021 - 2027 (USD Million)

TABLE 130. Diagnostic centers market size, by region, 2016 - 2020 (USD Million)

TABLE 131. Diagnostic centers market size, by region, 2021 - 2027 (USD Million)

TABLE 132. Research laboratories market size, by region, 2016 - 2020 (USD Million)

TABLE 133. Research laboratories market size, by region, 2021 - 2027 (USD Million)

TABLE 134. Home-care settings market size, by region, 2016 - 2020 (USD Million)

TABLE 135. Home-care settings market size, by region, 2021 - 2027 (USD Million)

TABLE 136. Others market size, by region, 2016 - 2020 (USD Million)

TABLE 137. Others market size, by region, 2021 - 2027 (USD Million)

TABLE 138. North America point of care testing market, by country, 2016 - 2020 (USD Million)

TABLE 139. North America point of care testing market, by country, 2021 - 2027 (USD Million)

TABLE 140. North America point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 141. North America point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 142. North America point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 143. North America point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 144. North America point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 145. North America point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 146. North America point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 147. North America point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 148. North America point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 149. North America point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 150. North America point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 151. North America point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 152. North America point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 153. North America point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 154. North America point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 155. North America point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 156. North America point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 157. North America point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 158. North America point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 159. North America point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 160. North America point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 161. North America point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 162. U.S. point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 163. U.S. point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 164. U.S. point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 165. U.S. point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 166. U.S. point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 167. U.S. point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 168. U.S. point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 169. U.S. point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 170. U.S. point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 171. U.S. point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 172. U.S. point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 173. U.S. point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 174. U.S. point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 175. U.S. point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 176. U.S. point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 177. U.S. point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 178. U.S. point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 179. U.S. point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 180. U.S. point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 181. U.S. point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 182. U.S. point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 183. U.S. point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 184. Canada point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 185. Canada point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 186. Canada point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 187. Canada point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 188. Canada point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 189. Canada point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 190. Canada point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 191. Canada point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 192. Canada point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 193. Canada point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 194. Canada point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 195. Canada point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 196. Canada point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 197. Canada point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 198. Canada point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 199. Canada point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 200. Canada point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 201. Canada point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 202. Canada point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 203. Canada point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 204. Canada point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 205. Canada point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 206. Europe point of care testing market, by country, 2016 - 2020 (USD Million)

TABLE 207. Europe point of care testing market, by country, 2021 - 2027 (USD Million)

TABLE 208. Europe point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 209. Europe point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 210. Europe point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 211. Europe point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 212. Europe point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 213. Europe point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 214. Europe point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 215. Europe point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 216. Europe point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 217. Europe point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 218. Europe point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 219. Europe point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 220. Europe point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 221. Europe point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 222. Europe point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 223. Europe point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 224. Europe point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 225. Europe point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 226. Europe point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 227. Europe point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 228. Europe point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 229. Europe point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 230. Germany point of care testing market testing, by product, 2016 - 2020 (USD Million)

TABLE 231. Germany point of care testing market testing, by product, 2021 - 2027 (USD Million)

TABLE 232. Germany point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 233. Germany point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 234. Germany point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 235. Germany point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 236. Germany point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 237. Germany point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 238. Germany point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 239. Germany point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 240. Germany point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 241. Germany point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 242. Germany point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 243. Germany point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 244. Germany point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 245. Germany point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 246. Germany point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 247. Germany point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 248. Germany point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 249. Germany point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 250. Germany point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 251. Germany point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 252. UK point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 253. UK point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 254. UK point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 255. UK point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 256. UK point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 257. UK point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 258. UK point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 259. UK point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 260. UK point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 261. UK point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 262. UK point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 263. UK point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 264. UK point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 265. UK point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 266. UK point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 267. UK point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 268. UK point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 269. UK point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 270. UK point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 271. UK point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 272. UK point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 273. UK point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 274. France point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 275. France point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 276. France point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 277. France point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 278. France point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 279. France point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 280. France point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 281. France point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 282. France point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 283. France point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 284. France point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 285. France point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 286. France point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 287. France point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 288. France point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 289. France point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 290. France point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 291. France point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 292. France point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 293. France point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 294. France point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 295. France point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 296. Italy point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 297. Italy point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 298. Italy point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 299. Italy point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 300. Italy point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 301. Italy point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 302. Italy point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 303. Italy point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 304. Italy point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 305. Italy point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 306. Italy point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 307. Italy point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 308. Italy point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 309. Italy point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 310. Italy point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 311. Italy point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 312. Italy point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 313. Italy point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 314. Italy point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 315. Italy point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 316. Italy point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 317. Italy point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 318. Spain point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 319. Spain point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 320. Spain point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 321. Spain point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 322. Spain point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 323. Spain point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 324. Spain point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 325. Spain point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 326. Spain point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 327. Spain point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 328. Spain point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 329. Spain point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 330. Spain point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 331. Spain point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 332. Spain point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 333. Spain point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 334. Spain point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 335. Spain point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 336. Spain point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 337. Spain point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 338. Spain point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 339. Spain point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 340. Asia Pacific point of care testing market, by country, 2016 - 2020 (USD Million)

TABLE 341. Asia Pacific point of care testing market, by country, 2021 - 2027 (USD Million)

TABLE 342. Asia Pacific point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 343. Asia Pacific point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 344. Asia Pacific point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 345. Asia Pacific point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 346. Asia Pacific point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 347. Asia Pacific point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 348. Asia Pacific point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 349. Asia Pacific point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 350. Asia Pacific point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 351. Asia Pacific point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 352. Asia Pacific point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 353. Asia Pacific point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 354. Asia Pacific point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 355. Asia Pacific point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 356. Asia Pacific point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 357. Asia Pacific point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 358. Asia Pacific point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 359. Asia Pacific point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 360. Asia Pacific point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 361. Asia Pacific point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 362. Asia Pacific point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 363. Asia Pacific point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 364. China point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 365. China point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 366. China point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 367. China point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 368. China point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 369. China point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 370. China point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 371. China point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 372. China point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 373. China point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 374. China point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 375. China point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 376. China point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 377. China point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 378. China point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 379. China point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 380. China point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 381. China point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 382. China point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 383. China point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 384. China point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 385. China point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 386. Japan point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 387. Japan point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 388. Japan point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 389. Japan point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 390. Japan point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 391. Japan point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 392. Japan point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 393. Japan point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 394. Japan point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 395. Japan point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 396. Japan point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 397. Japan point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 398. Japan point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 399. Japan point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 400. Japan point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 401. Japan point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 402. Japan point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 403. Japan point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 404. Japan point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 405. Japan point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 406. Japan point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 407. Japan point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 408. India point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 409. India point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 410. India point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 411. India point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 412. India point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 413. India point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 414. India point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 415. India point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 416. India point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 417. India point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 418. India point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 419. India point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 420. India point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 421. India point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 422. India point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 423. India point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 424. India point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 425. India point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 426. India point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 427. India point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 428. India point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 429. India point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 430. Australia point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 431. Australia point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 432. Australia point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 433. Australia point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 434. Australia point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 435. Australia point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 436. Australia point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 437. Australia point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 438. Australia point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 439. Australia point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 440. Australia point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 441. Australia point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 442. Australia point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 443. Australia point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 444. Australia point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 445. Australia point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 446. Australia point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 447. Australia point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 448. Australia point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 449. Australia point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 450. Australia point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 451. Australia point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 452. Latin America point of care testing market, by country, 2016 - 2020 (USD Million)

TABLE 453. Latin America point of care testing market, by country, 2021 - 2027 (USD Million)

TABLE 454. Latin America point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 455. Latin America point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 456. Latin America point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 457. Latin America point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 458. Latin America point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 459. Latin America point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 460. Latin America point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 461. Latin America point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 462. Latin America point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 463. Latin America point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 464. Latin America point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 465. Latin America point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 466. Latin America point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 467. Latin America point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 468. Latin America point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 469. Latin America point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 470. Latin America point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 471. Latin America point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 472. Latin America point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 473. Latin America point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 474. Latin America point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 475. Latin America point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 476. Brazil point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 477. Brazil point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 478. Brazil point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 479. Brazil point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 480. Brazil point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 481. Brazil point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 482. Brazil point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 483. Brazil point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 484. Brazil point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 485. Brazil point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 486. Brazil point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 487. Brazil point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 488. Brazil point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 489. Brazil point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 490. Brazil point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 491. Brazil point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 492. Brazil point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 493. Brazil point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 494. Brazil point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 495. Brazil point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 496. Brazil point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 497. Brazil point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 498. Mexico point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 499. Mexico point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 500. Mexico point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 501. Mexico point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 502. Mexico point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 503. Mexico point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 504. Mexico point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 505. Mexico point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 506. Mexico point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 507. Mexico point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 508. Mexico point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 509. Mexico point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 510. Mexico point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 511. Mexico point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 512. Mexico point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 513. Mexico point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 514. Mexico point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 515. Mexico point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 516. Mexico point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 517. Mexico point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 518. Mexico point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 519. Mexico point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 520. Middle East and Africa point of care testing market, by country, 2016 - 2020 (USD Million)

TABLE 521. Middle East and Africa point of care testing market, by country, 2021 - 2027 (USD Million)

TABLE 522. Middle East and Africa point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 523. Middle East and Africa point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 524. Middle East and Africa point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 525. Middle East and Africa point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 526. Middle East and Africa point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 527. Middle East and Africa point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 528. Middle East and Africa point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 529. Middle East and Africa point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 530. Middle East and Africa point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 531. Middle East and Africa point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 532. Middle East and Africa point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 533. Middle East and Africa point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 534. Middle East and Africa point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 535. Middle East and Africa point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 536. Middle East and Africa point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 537. Middle East and Africa point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 538. Middle East and Africa point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 539. Middle East and Africa point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 540. Middle East and Africa point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 541. Middle East and Africa point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 542. Middle East and Africa point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 543. Middle East and Africa point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 544. South Africa point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 545. South Africa point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 546. South Africa point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 547. South Africa point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 548. South Africa point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 549. South Africa point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 550. South Africa point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 551. South Africa point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 552. South Africa point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 553. South Africa point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 554. South Africa point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 555. South Africa point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 556. South Africa point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 557. South Africa point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 558. South Africa point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 559. South Africa point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 560. South Africa point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 561. South Africa point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 562. South Africa point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 563. South Africa point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 564. South Africa point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 565. South Africa point of care testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 566. Saudi Arabia point of care testing market, by product, 2016 - 2020 (USD Million)

TABLE 567. Saudi Arabia point of care testing market, by product, 2021 - 2027 (USD Million)

TABLE 568. Saudi Arabia point of care testing market size, by glucose monitoring, 2016 - 2020 (USD Million)

TABLE 569. Saudi Arabia point of care testing market size, by glucose monitoring, 2021 - 2027 (USD Million)

TABLE 570. Saudi Arabia point of care testing market size, by cardiometabolic testing products, 2016 - 2020 (USD Million)

TABLE 571. Saudi Arabia point of care testing market size, by cardiometabolic testing products, 2021 - 2027 (USD Million)

TABLE 572. Saudi Arabia point of care testing market size, by cardiac marker testing products, 2016 - 2020 (USD Million)

TABLE 573. Saudi Arabia point of care testing market size, by cardiac marker testing products, 2021 - 2027 (USD Million)

TABLE 574. Saudi Arabia point of care testing market size, by infectious disease testing products, 2016 - 2020 (USD Million)

TABLE 575. Saudi Arabia point of care testing market size, by infectious disease testing products, 2021 - 2027 (USD Million)

TABLE 576. Saudi Arabia point of care testing market size, by coagulation testing products, 2016 - 2020 (USD Million)

TABLE 577. Saudi Arabia point of care testing market size, by coagulation testing products, 2021 - 2027 (USD Million)

TABLE 578. Saudi Arabia point of care testing market size, by pregnancy and fertility testing products, 2016 - 2020 (USD Million)

TABLE 579. Saudi Arabia point of care testing market size, by pregnancy and fertility testing products, 2021 - 2027 (USD Million)

TABLE 580. Saudi Arabia point of care testing market, by technology, 2016 - 2020 (USD Million)

TABLE 581. Saudi Arabia point of care testing market, by technology, 2021 - 2027 (USD Million)

TABLE 582. Saudi Arabia point of care testing market, by prescription, 2016 - 2020 (USD Million)

TABLE 583. Saudi Arabia point of care testing market, by prescription, 2021 - 2027 (USD Million)

TABLE 584. Saudi Arabia point of care testing market, by application, 2016 - 2020 (USD Million)

TABLE 585. Saudi Arabia point of care testing market, by application, 2021 - 2027 (USD Million)

TABLE 586. Saudi Arabia point of care testing market, by end-use, 2016 - 2020 (USD Million)

TABLE 587. Saudi Arabia point of care testing market, by end-use, 2021 - 2027 (USD Million)
 

Charts & Figures

FIG 1.   Top-down approach

FIG 2.   Breakdown of primary participants

FIG 3.   Point of care industry 3600 synopsis, 2016 - 2027

FIG 4.   Industry segmentation

FIG 5.   Global Point of care testing market size, 2016 - 2027 (USD Million)

FIG 6.   Growth potential analysis, by product

FIG 7.   Growth potential analysis, by technology

FIG 8.   Growth potential analysis, by prescription

FIG 9.   Growth potential analysis, by application

FIG 10. Growth potential analysis, by end-use

FIG 11. Global market share analysis, 2020

FIG 12. Company share analysis, 2020 - North America

FIG 13. Company share analysis, 2020 - Europe

FIG 14. Company share analysis, 2020 – Asia Pacific

FIG 15. Company share analysis, 2020 – Latin America

FIG 16. Company share analysis, 2020 – Middle East and Africa

FIG 17. Porter’s analysis

FIG 18. Global company market share analysis, 2020

FIG 19. Company matrix analysis, 2020

FIG 20. PESTEL analysis

FIG 21. Key segmental trends, by product

FIG 22. Key segmental trends, by technology

FIG 23. Key segmental trends, by prescription

FIG 24. Key segmental trends, by application

FIG 25. Key segmental trends, by end-use

FIG 26. Key regional trends

FIG 27. Competitive dashboard

 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2020
  • Companies covered: 20
  • Tables & Figures: 614
  • Countries covered: 15
  • Pages: 400

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount